These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12355680)

  • 1. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence.
    Smelson DA; Losonczy MF; Davis CW; Kaune M; Williams J; Ziedonis D
    Can J Psychiatry; 2002 Sep; 47(7):671-5. PubMed ID: 12355680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients.
    Smelson DA; Williams J; Ziedonis D; Sussner BD; Losonczy MF; Engelhart C; Kaune M
    J Subst Abuse Treat; 2004 Jul; 27(1):45-9. PubMed ID: 15223093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients.
    Copersino ML; Serper MR; Vadhan N; Goldberg BR; Richarme D; Chou JC; Stitzer M; Cancro R
    Psychiatry Res; 2004 Oct; 128(3):209-18. PubMed ID: 15541777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.
    Smelson DA; Ziedonis D; Williams J; Losonczy MF; Williams J; Steinberg ML; Kaune M
    J Clin Psychopharmacol; 2006 Feb; 26(1):9-12. PubMed ID: 16415698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study.
    Levin FR; Evans SM; Coomaraswammy S; Collins ED; Regent N; Kleber HD
    Am J Drug Alcohol Abuse; 1998 Aug; 24(3):343-60. PubMed ID: 9741939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.
    Akerele E; Levin FR
    Am J Addict; 2007; 16(4):260-8. PubMed ID: 17661193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone in cocaine-dependent patients with comorbid psychiatric disorders.
    Albanese MJ; Suh JJ
    J Psychiatr Pract; 2006 Sep; 12(5):306-11. PubMed ID: 16998418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group.
    Chouinard G; Kopala L; Labelle A; Beauclair L; Johnson SV; Singh KI
    Can J Psychiatry; 1998 Dec; 43(10):1018-25. PubMed ID: 9868567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
    Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders.
    Stuyt EB; Sajbel TA; Allen MH
    Am J Addict; 2006; 15(2):166-73. PubMed ID: 16595355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone diminishes cue-elicited craving in withdrawn cocaine-dependent patients.
    Smelson DA; Roy A; Roy M
    Can J Psychiatry; 1997 Nov; 42(9):984. PubMed ID: 9429074
    [No Abstract]   [Full Text] [Related]  

  • 15. Risperidone, ERG and cocaine craving.
    Roy A; Roy M; Smelson DA
    Am J Addict; 1998; 7(1):90. PubMed ID: 9522012
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone: how good is the evidence for efficacy?
    Mattes JA
    Schizophr Bull; 1997; 23(1):155-61. PubMed ID: 9050121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of olanzapine and risperidone in schizophrenia: a randomized double-blind crossover design.
    Canive JM; Miller GA; Irwin JG; Moses SN; Thoma RJ; Edgar JC; Sherwood A; Torres F; Lanoue M; Lewis S; Hanlon FM; Weisend MP; Mead V; Tuason VB
    Psychopharmacol Bull; 2006; 39(1):105-16. PubMed ID: 17065975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
    Kane JM; Potkin SG; Daniel DG; Buckley PF
    J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can risperidone reduce cocaine use in substance abusing schizophrenic patients?
    Tsuang JW; Eckman T; Marder S; Tucker D
    J Clin Psychopharmacol; 2002 Dec; 22(6):629-30. PubMed ID: 12454567
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J; López-Carrilero R; Iniesta R; Roca M; Caballero M; Rodriguez-Jimenez R; Oliveira C; Bernardo M; Corripio I; Sindreu SD; González Piqueras JC; Felipe AE; Fernandez de Corres B; Ibáñez A; Huerta R;
    J Clin Psychiatry; 2014 Jun; 75(6):608-15. PubMed ID: 25004184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.